Lexogen Completes 120,000-Sample Functional Genomics Project With Ochre Bio

 Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion of a large-scale...

November 26, 2025 | Wednesday | News
Macomics Validates ENIGMAC™ Platform for First-in-Class Antifibrotic Target Discovery

Macomics Ltd, a leader in macrophage drug discovery, announces that it has validated its ENIGMAC™ platform in macrophage mediated antifibrotic ther...

November 26, 2025 | Wednesday | News
MindImmune Closes $10.2M Series A Extension to Advance First-in-Class Alzheimer’s Therapeutic

MindImmune Therapeutics, a private company developing new treatments targeting the inflammatory drivers of neurodegenerative disease, announced two major...

November 25, 2025 | Tuesday | News
Thermo Fisher’s Oncomine Dx Target Test Gains FDA Approval as CDx for Bayer’s Newly Approved HYRNUO™

  Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with NSCLC eligible for HER2-targeted...

November 20, 2025 | Thursday | News
BriaPro Launches AI-Driven Collaboration With Receptor.AI to Design Isoform-Selective Anti-Cancer Kinase Inhibitors

Collaboration uses Receptor AI's platform to design highly selective anti-cancer kinase inhibitor products for BriaPro, a BriaCell subsidiary Partners...

November 21, 2025 | Friday | News
Profluent Raises $106M to Accelerate Frontier AI for Programmable Biology

Profluent, a leader in frontier AI for protein design,  announced a $106 million financing co-led by Altimeter Capital and Bezos Expeditions, with p...

November 20, 2025 | Thursday | News
PrognomiQ Launches ProVue Lung, a Blood-Based Test Designed for Earlier Lung Cancer Detection

Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny Health Network –  Pr...

November 19, 2025 | Wednesday | News
Scotland Strengthens Position as Global Brain Health Innovator With New Alzheimer’s Research Centre in Aberdeen

Aberdeen clinical research centre widens access to clinical trials across Scotland, advancing early Alzheimer’s research ONE BioHub provides Scott...

November 18, 2025 | Tuesday | News
New England Biolabs Launches Integrated Indexing Primer Module for Streamlined Influenza A Sequencing on Oxford Nanopore Technologies Platforms

Streamlined, high-throughput sequencing of Influenza A virus with integrated indexing for Oxford Nanopore Technologies® platforms New England Biolab...

November 14, 2025 | Friday | News
Callan JMB Enters Agreement to Host Oral Drug Delivery Manufacturing at Texas cGMP Facility

Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare indust...

November 14, 2025 | Friday | News
Vascarta and CUNY Report Preclinical Breakthrough Demonstrating STO-1 Selectively Eliminates Glioblastoma Cells

Vascarta Inc., a healthspan focused, clinical stage biopharmaceutical company advancing safe, patient friendly therapies for pain, inflammation, and, in ...

November 11, 2025 | Tuesday | News
Facet Life Sciences and XCancer Form Strategic Partnership to Accelerate Development of Theranostic Radiopharmaceuticals

Facet Life Sciences, a leader in regulatory strategy and drug development services, announced a strategic partnership with XCancer®, a global leader ...

November 07, 2025 | Friday | News
Aceso and Samsung Partner to Advance Digital Transformation in Hospital Communication and Patient Care

-Aceso Interactive, Inc., a leading provider of patient engagement and healthcare communication technology, is pleased to announce a strategic partnershi...

November 07, 2025 | Friday | News
Eli Lilly to Invest $3 Billion in New European Manufacturing Facility at Leiden Bio Science Park, Netherlands

Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain Eli Lilly and Company ...

November 04, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close